Net Loss per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||||||||||
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||||||
| Antidilutive Securities | 64,814,447 | 46,557,537 | 64,814,447 | 46,557,537 | 24,199,613 | 23,097,930 | ||||||||||||||
| Convertible preferred stock [Member] | ||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||||||
| Antidilutive Securities | 17,863,934 | 17,863,934 | 17,863,934 | 17,863,934 | 17,863,934 | 17,863,934 | ||||||||||||||
| Convertible notes payable [Member] | ||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||||||
| Antidilutive Securities | 42,430,263 | [1] | 25,721,548 | [1] | 42,430,263 | [1] | 25,721,548 | [1] | 3,363,624 | 2,251,941 | [2] | |||||||||
| Convertible loans [Member] | ||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||||||
| Antidilutive Securities | [3] | [3] | [3] | [3] | [4] | |||||||||||||||
| Options to purchase common stock [Member] | ||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||||||
| Antidilutive Securities | 4,520,250 | 2,972,055 | 4,520,250 | 2,972,055 | 2,972,055 | 2,982,055 | ||||||||||||||
| ||||||||||||||||||||